{"id":"long-acting-methylphenidate","safety":{"commonSideEffects":[{"rate":"10-20","effect":"Insomnia"},{"rate":"10-20","effect":"Decreased appetite"},{"rate":"5-15","effect":"Headache"},{"rate":"5-10","effect":"Abdominal pain"},{"rate":"5-10","effect":"Nervousness or anxiety"},{"rate":"5-10","effect":"Tachycardia"},{"rate":"5-10","effect":"Elevated blood pressure"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Methylphenidate blocks the reuptake of dopamine and norepinephrine at the presynaptic neuron, increasing their concentration in the synaptic cleft. The long-acting formulation extends the duration of action, typically providing symptom control for 8-12 hours with a single daily dose. This mechanism enhances attention, focus, and impulse control in patients with attention deficit hyperactivity disorder.","oneSentence":"Long-acting methylphenidate is a sustained-release formulation of a central nervous system stimulant that increases dopamine and norepinephrine availability in the brain by inhibiting their reuptake.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:52:52.759Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Attention deficit hyperactivity disorder (ADHD) in children and adults"}]},"trialDetails":[{"nctId":"NCT03511976","phase":"PHASE4","title":"Adaptive Response to Intervention (RTI) for Students With ADHD","status":"WITHDRAWN","sponsor":"Florida International University","startDate":"2018-05-14","conditions":"Attention Deficit Disorder With Hyperactivity","enrollment":""},{"nctId":"NCT00754208","phase":"PHASE4","title":"Long Acting Stimulant Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Young Children","status":"COMPLETED","sponsor":"University of Nebraska","startDate":"2008-09-18","conditions":"Attention Deficit Hyperactivity Disorder","enrollment":7},{"nctId":"NCT04968522","phase":"PHASE4","title":"FASST - Fetal Alcohol Spectrum Stimulant Trial","status":"UNKNOWN","sponsor":"Monash Medical Centre","startDate":"2022-02-14","conditions":"Fetal Alcohol Spectrum Disorders","enrollment":20},{"nctId":"NCT02063945","phase":"PHASE4","title":"Methylphenidate vs. Risperidone for the Treatment of Children and Adolescents With ADHD and Disruptive Disorders","status":"TERMINATED","sponsor":"Sheba Medical Center","startDate":"2017-02-01","conditions":"Attention Deficit/Hyperactivity Disorder, Oppositional Defiant Disorder, Conduct Disorder","enrollment":5},{"nctId":"NCT03709940","phase":"NA","title":"Brain Connectivity in Attention Deficit Hyperactivity Disorder (ADHD)","status":"COMPLETED","sponsor":"King's College London","startDate":"2013-05-03","conditions":"Attention Deficit Hyperactivity Disorder (ADHD)","enrollment":60},{"nctId":"NCT02675400","phase":"PHASE4","title":"Treatments for Fathers With ADHD and Their At-Risk Children (Fathers Too)","status":"COMPLETED","sponsor":"Seattle Children's Hospital","startDate":"2015-12","conditions":"Attention Deficit/Hyperactivity Disorder (ADHD)","enrollment":19},{"nctId":"NCT02142140","phase":"NA","title":"Follow up Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)","status":"UNKNOWN","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2012-12","conditions":"Attention Deficit Hyperactivity Disorder (ADHD)","enrollment":326},{"nctId":"NCT00863499","phase":"PHASE4","title":"International Study to Predict Optimised Treatment in Attention Deficit/Hyperactivity Disorder","status":"UNKNOWN","sponsor":"BRC Operations Pty. Ltd.","startDate":"2009-10","conditions":"Attention Deficit/Hyperactivity Disorder","enrollment":1344},{"nctId":"NCT02778360","phase":"PHASE1, PHASE2","title":"Effectiveness of a Personalized Neurofeedback Training Device (ADHD@Home) in Attention-Deficit/Hyperactivity Disorder","status":"UNKNOWN","sponsor":"Mensia Technologies SA","startDate":"2016-08","conditions":"Attention Deficit-Hyperactivity Disorder","enrollment":179},{"nctId":"NCT00376675","phase":"PHASE3","title":"Methylphenidate in Treating Patients With Fatigue Caused by Cancer","status":"COMPLETED","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2008-02","conditions":"Fatigue, Unspecified Adult Solid Tumor, Protocol Specific","enrollment":148},{"nctId":"NCT02501798","phase":"PHASE4","title":"The Effects of Long-acting Methylphenidate on Academic Activity and Related Constructs in Children With ADHD","status":"COMPLETED","sponsor":"VU University of Amsterdam","startDate":"2013-01","conditions":"Attention Deficit Hyperactivity Disorder","enrollment":61},{"nctId":"NCT00593138","phase":"PHASE1, PHASE2","title":"Study of Dopamine Transporter Receptor Occupancy With Long-acting Dex-methylphenidate","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2006-12","conditions":"Drug Binding to DAT Receptors","enrollment":23},{"nctId":"NCT00783835","phase":"PHASE4","title":"Study to Evaluate the Efficacy and Quality of Life of Long-Acting Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD)","status":"COMPLETED","sponsor":"Janssen-Cilag Farmaceutica Ltda.","startDate":"2008-02","conditions":"Attention Deficit Hyperactivity Disorder","enrollment":60},{"nctId":"NCT01599975","phase":"PHASE3","title":"A Study Comparing Long-acting Methylphenidate (ConcertaTM) vs. Placebo in the Treatment of Memory Loss Due to HIV","status":"UNKNOWN","sponsor":"University of California, Los Angeles","startDate":"2012-05","conditions":"HIV Dementia","enrollment":40},{"nctId":"NCT00302354","phase":"PHASE4","title":"A Double-blind Randomized, Placebo-controlled, Crossover Study of Single Doses of OROS Methylphenidate Hydrochloride (CONCERTA) and Long-acting Methylphenidate Hydrochloride (RITALIN LA) in Healthy Adults","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2004-12","conditions":"Healthy Volunteers","enrollment":50},{"nctId":"NCT00301639","phase":"PHASE3","title":"A PET Study Examining Pharmacokinetics and Dopamine Transporter Receptor Occupancy Of Two Long-Acting Formulations of Methylphenidate in Adults","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2005-03","conditions":"Healthy Volunteers","enrollment":40},{"nctId":"NCT00428792","phase":"PHASE3","title":"Safety and Efficacy of Methylphenidate in Children With Attention-deficit Hyperactivity Disorder (ADHD)","status":"COMPLETED","sponsor":"Novartis","startDate":"2007-04","conditions":"Attention Deficit Hyperactivity Disorder","enrollment":150},{"nctId":"NCT01124500","phase":"NA","title":"Transdermal Methylphenidate for Cancer-Related Fatigue","status":"WITHDRAWN","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2010-05","conditions":"Head and Neck Cancer","enrollment":""}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":87,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Concerta","• Concerta","• Metadate CD","• Methylin ER","• Ritalin LA"],"phase":"marketed","status":"active","brandName":"Long acting methylphenidate","genericName":"Long acting methylphenidate","companyName":"University of California, Los Angeles","companyId":"university-of-california-los-angeles","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Long-acting methylphenidate is a sustained-release formulation of a central nervous system stimulant that increases dopamine and norepinephrine availability in the brain by inhibiting their reuptake. Used for Attention-deficit/hyperactivity disorder (ADHD), Narcolepsy.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}